Skip to main content
. Author manuscript; available in PMC: 2016 Feb 9.
Published in final edited form as: Psychosom Med. 2014 Apr;76(3):215–220. doi: 10.1097/PSY.0000000000000050

Table 5. Stage-Appropriate Treatment among Patients with and without Schizophrenia.

Stage No Schizophrenia
N (%)
Schizophrenia
N (%)
Treatment among Patients with Schizophrenia
Unadjusted2
OR1 (95% CI)
Adjusted3
OR (95% CI)
All Stages 45,365 (49.1) 484 (38.4) 0.65 (0.58-0.73) 0.50 (0.43-0.58)
Stage I-IIIA
  Surgery 23,519 (60.5) 313 (53.0) 0.73 (0.62-0.86) 0.82 (0.68-0.98)
Resected Stage II-IIIA
  Adjuvant Chemotherapy 1,132 (17.7) ≤ 11 (14.9) 0.81 (0.43-1.54) 0.84 (0.44-1.62)
Unresected Stage I-II
  Radiation Therapy 5,261 (62.7) 84 (51.5) 0.63 (0.46-0.86) 0.62 (0.45-0.85)
Stage IIIB
  Radiation and Chemotherapy 4,225 (22.2) 27 (10.2) 0.39 (0.26-0.60) 0.39 (0.26-0.58)
  Radiation or Chemotherapy 7,689 (40.4) 91 (34.5)
  Neither 7,106 (37.4) 146 (55.3)
Stage IV
  Chemotherapy 12,981 (36.5) 70 (16.9) 0.36 (0.28-0.48) 0.39 (0.30-0.50)
1

OR = odds ratio

2

Logistic regression model, unadjusted

3

Logistic regression model, adjusted for age, gender, marital status, race/ethnicity, income, histology, and comorbidities